XRAY Stock Overview
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
DENTSPLY SIRONA Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$33.31 |
52 Week High | US$43.24 |
52 Week Low | US$26.27 |
Beta | 1.0 |
1 Month Change | -1.13% |
3 Month Change | -6.41% |
1 Year Change | -11.69% |
3 Year Change | -47.80% |
5 Year Change | -33.84% |
Change since IPO | 4,672.77% |
Recent News & Updates
Recent updates
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues
Mar 10Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden
Feb 16DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward
Jan 29DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jan 11Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Nov 25These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively
Nov 06Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture
Oct 15An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued
Sep 18DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet
Jul 31The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing
Jul 09A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Jun 20When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Jun 02Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel
May 15The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing
Apr 05Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?
Mar 07We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt
Nov 09Dentsply Sirona names Glenn Coleman as new CFO
Sep 22Dentsply Sirona hires Simon Campion as president, CEO
Aug 25Dentsply Sirona receives noncompliance notice from Nasdaq
Aug 16Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument
Jul 18Dentsply Sirona Seems Unaffected By Management Reshuffles
May 02Investors Will Want DENTSPLY SIRONA's (NASDAQ:XRAY) Growth In ROCE To Persist
Apr 29DENTSPLY SIRONA (NASDAQ:XRAY) Seems To Use Debt Rather Sparingly
Mar 16Shareholder Returns
XRAY | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0.03% | 2.2% | 0.4% |
1Y | -11.7% | 13.3% | 28.8% |
Return vs Industry: XRAY underperformed the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: XRAY underperformed the US Market which returned 29.5% over the past year.
Price Volatility
XRAY volatility | |
---|---|
XRAY Average Weekly Movement | 3.5% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: XRAY has not had significant price volatility in the past 3 months.
Volatility Over Time: XRAY's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1877 | 15,000 | Simon Campion | https://www.dentsplysirona.com |
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
DENTSPLY SIRONA Inc. Fundamentals Summary
XRAY fundamental statistics | |
---|---|
Market cap | US$6.91b |
Earnings (TTM) | -US$132.00m |
Revenue (TTM) | US$3.97b |
1.7x
P/S Ratio-52.3x
P/E RatioIs XRAY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XRAY income statement (TTM) | |
---|---|
Revenue | US$3.97b |
Cost of Revenue | US$1.88b |
Gross Profit | US$2.09b |
Other Expenses | US$2.22b |
Earnings | -US$132.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.64 |
Gross Margin | 52.71% |
Net Profit Margin | -3.33% |
Debt/Equity Ratio | 64.8% |
How did XRAY perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield-90%
Payout RatioDoes XRAY pay a reliable dividends?
See XRAY dividend history and benchmarksDENTSPLY SIRONA dividend dates | |
---|---|
Ex Dividend Date | Mar 27 2024 |
Dividend Pay Date | Apr 12 2024 |
Days until Ex dividend | 1 day |
Days until Dividend pay date | 15 days |
Does XRAY pay a reliable dividends?
See XRAY dividend history and benchmarks